A global life sciences and healthcare company is closing a Massachusetts facility and laying off nearly 100 people.
U.S. House representatives heard the clinical lab industry plead yesterday for a reprieve from looming cuts as large as 15% ...
For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
As a result of the acquisition, NAMSA assumes the U.S. portfolio of services of Labcorp’s Early Development medical device ...
Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality ResultsSAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will ...
Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...
Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...
Key market opportunities in the autism spectrum disorder diagnostics sector include growth in the autistic disorder segment, ...
Healthcare Dealmakers—$6B NJ hospital merger nixed, Blue Cross KC affiliating with Highmark and more
Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry ...
Labcorp is a global leader of innovative and comprehensive laboratory services. The company's Venture Fund invests in and supports early stage, private companies that are focused on improving health ...
LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback